Bayer invests 130 million EUR in new production facility for innovative parenteral products Ruchika Sharma26 Nov 2023 10:00 AM ISTBerlin: Bayer has added a brand new manufacturing facility to its global supply chain network. The new production plant was inaugurated at the...
Ajanta Pharma Gets CDSCO Panel Nod To Study Antihypertensive FDC Dr. Divya Colin25 Nov 2023 6:00 PM ISTNew Delhi: Ajanta Pharma has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Bayer Monsanto hit with USD 165 million verdict over PCBs in Seattle school Ruchika Sharma25 Nov 2023 5:04 PM ISTA U.S. jury has ordered Bayer's Monsanto to pay $165 million to employees of a school northeast of Seattle who claimed chemicals made by the company...
Novo Nordisk to launch popular anti-obesity drug Wegovy in Japan Ruchika Sharma25 Nov 2023 4:41 PM ISTThe monthly cost for patients will be 7,504 Japanese yen ($50.15) for a 0.25-milligram starter dose and 42,960 yen for a 2.4 mg dose, Novo said.
Texas AG sues Pfizer over quality control lapses in kids ADHD drug Ruchika Sharma25 Nov 2023 3:08 PM ISTThe lawsuit also alleged that Pfizer, despite knowing of the quality-control issues, persuaded Texas' Medicaid program to add Quillivant to its list...
Gland Pharma gets USFDA EIR for Pashamylaram facility Ruchika Sharma25 Nov 2023 11:48 AM ISTHyderabad: Gland Pharma has recently announced that the Company has received an Establishment Inspection Report (EIR) from the US FDA indicating the...
Global Dental Services, parent of Clove Dental gets Rs 417 crore from Qatar Investment Authority Ruchika Sharma24 Nov 2023 3:38 PM ISTMumbai: Investcorp-backed Global Dental Services, the powerhouse behind Clove Dental—one of the largest dental clinic chains in India—has received a...
Boehringer Ingelheim receives approval for Senvelgo in Europe for diabetic cats Ruchika Sharma24 Nov 2023 3:30 PM ISTFeline diabetes mellitus is a metabolic disorder which occurs when a cat has insufficient levels of, or an abnormal response to insulin.
Boehringer Ingelheim expands immuno oncology portfolio with acquisition of bacterial cancer therapy specialist T3 Pharma Ruchika Sharma24 Nov 2023 1:30 PM ISTGermany: Boehringer Ingelheim has announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...
USFDA approves Lupin Bromfenac Ophthalmic Solution Ruchika Sharma24 Nov 2023 12:30 PM ISTBromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have...
Lupin type 2 diabetes drug Canagliflozin bags USFDA tentative approval Ruchika Sharma24 Nov 2023 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
GSK to start phase 3 trials of low-carbon Ventolin inhaler in 2024 Ruchika Sharma23 Nov 2023 3:26 PM ISTLondon: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a...
